Recognizing and Managing Growth Hormone Deficiency in Pediatric and Adult Patients: What Physicians and Patients Need to Know

FACULTY

Craig A. Alter, MD
Professor of Clinical Pediatrics
Director, Neuroendocrine Center
Division of Endocrinology and Diabetes
Children’s Hospital of Philadelphia
Philadelphia, PA

Maureen Dever, MSN, CRNP, PPCNP-BC, CDCES
Pediatric Nurse Practitioner
Division of Endocrinology/Diabetes
The Hub for Clinical Collaboration
Division of Endocrinology
Philadelphia, PA

Kevin Yuen, MD, FRCP (UK), FACE, FEAA
Professor of Medicine and Medical Director
Barrow Neurological Institute Pituitary Center
St. Joseph’s Hospital and Medical Center
University of Arizona College of Medicine
Creighton School of Medicine
Phoenix, AZ

PROGRAM OVERVIEW

The enduring activity with specialty tracks of content has been designed to meet the educational needs of US-based health care providers who treat patients with Growth Hormone Deficiency (GHD), as well as patients and their caregivers. This program will help participants better: assess the tools used to diagnose patients quickly and accurately; evaluate results of approved and emerging therapies for the treatment of pediatric and adult patients with GHD from clinical trials; summarize the long‐term management of strategies on the dosing and monitoring of pediatric and adult patients with GHD; facilitate continuity of care for pediatric patients transitioning into adulthood.

TARGET AUDIENCE

This activity is intended to meet the educational needs of US-based health care providers, particularly endocrinologists and pediatric endocrinologists, as well as the multidisciplinary team including nurse practitioners and physician assistants who treat patients with GHD, as well as patients and caregivers.

LEARNING OBJECTIVES

Upon the completion of this program, attendees should be able to:

• Assess the diagnostic tools that can be used to facilitate a timely and accurate diagnosis of GHD in pediatric and adult patients
• Evaluate results from clinical trials of approved and emerging therapies for the treatment of pediatric and adult patients with GHD
• Summarize dosing and monitoring strategies for the long‐term management of pediatric and adult patients with GHD
• Facilitate continuity of care for pediatric patients transitioning into adulthood

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.

PHYSICIAN CREDIT DESIGNATION STATEMENT

Med Learning Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

JOINT ACCREDITATION STATEMENT

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Med Learning Group. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

NURSES (ANCC) CREDIT DESIGNATION

Amedco LLC designates this activity for a maximum of 1.0 ANCC contact hour.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS

All relevant financial relationships have been mitigated.

CME Content Review

The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.

CNE Content Review

The content of this activity was peer reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.

Staff Planners and Managers

The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME/CE activity:

• Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
• Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
• Vaidehee Deshpande, Ph.D., Medical Director for Med Learning Group, has nothing to disclose.
• Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
• Marissa Mays-Verman, Program Manager for Med Learning Group, has nothing to disclose.
• Alexis Klinger, Program Coordinator for Med Learning Group, has nothing to disclose.
• Aimee Meissner, Accreditation and Outcomes Coordinator, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at [email protected]

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]

RELEASED DATE: November 20, 2023
EXPIRATION DATE: November 20, 2024